You are here > Services > Research and Development > Our current areas of Research > Cancer Studies > General Oncology Cancer Studies

General Oncology Cancer Studies


A phase III, double-blind, placebo-controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.

Study Area: General Oncology

Aim: To assess whether regular aspirin use after standard therapy (surgery, chemotherapy, radiotherapy or combinations thereof) prevents recurrence and prolongs survival in participants with non-metastatic common solid tumours.

Who can participate: Men and women aged over 16 who have recently had curative treatment for Breast, Prostate, Colorectal, Oesophageal or Gastric Cancer and who are able to take a daily dose of Aspirin for up to 5 years.

If you would like any further information on the following studies, and to find out if you are eligible please contact:


Address: R&D office, C254, West Wing, Broomfield Hospital, Court Road, Chelmsford, Essex, CM1 7ET

Telephone: 01245 515136
Email: Research@meht.nhs.uk